Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock

Efficacy of an IgM preparation in the treatment of patients with sepsis: a double-blind randomized clinical trial in a pediatric intensive care unit

Kola, Ermira
Çelaj, Ermela
Bakalli, Iliriana
Lluka, Robert
Kuli-Lito, Gjeorgjina
Sallabanda, Sashenka

December 2015

Aim: Additional treatments for sepsis to be administered alongside the standard therapy recommended ...

The Role of IgM-Enriched Immunoglobulin (Pentaglobin) in Septic Patients with Hematological Disease

Pedro Amoedo Fernandes
Flávia Tobaldini Russo
Lucas Augusto Monetta da Silva
Lafayete William Ferreira Ramos
Aline de Almeida Simões
Larissa Yukari Okada
Jamilla Neves Cavalcante
Maricy Almeida Viol Ferreira Lopes
Maria Cristina Martins de Almeida Macedo
Roberto Luiz da Silva

April 2021

Background: Patients with hematological disease are 15 times more likely to develop sepsis than the ...

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers

Scarpati G.
Baldassarre D.
Tripepi G.
Boffardi M.
Piazza O.

January 2021

Patients in septic shock with low IgG and IgM serum concentrations have higher mortality rates compa...

Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock

Cavazzuti, Ilaria
Serafini, Giulia
Busani, Stefano
Rinaldi, Laura
Biagioni, Emanuela
Buoncristiano, Marta
Girardis, Massimo

January 2014

To determine whether there was an association between adjunctive therapy with IgM-enriched immunoglo...

Effects of IgM-enriched immunoglobulin therapy in septic-shock-induced multiple organ failure: Pilot study

Toth, Ildiko
Mikor, Andras
Leiner, Tamas
Molnar, Zsolt
Bogar, Lajos
Szakmany, Tamas

August 2013

Mortality due to septic-shock–induced respiratory failure remains high. A recent meta-analysis sugge...

Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum igm-titres versus standard dose in the treatment of septic shock: A randomised controlled trial (igm-fat trial)

Biagioni E.
Tosi M.
Berlot G.
Castiglione G.
Corona A.
De Cristofaro M. G.
Donati A.
Feltracco P.
Forfori F.
Fragranza F.
Murino P.
Piazza O.
Tullo L.
Grasselli G.
D'Amico R.
Girardis M.

January 2021

Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...

Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial)

Patrizia Murino
Emanuela Biagioni
Martina Tosi
Giorgio Berlot
Giacomo Castiglione
Alberto Corona
Maria Giovanna De Cristofaro
Abele Donati
Paolo Feltracco
Francesco Forfori
Fiorentino Fragranza
Ornella Piazza
Livio Tullo
Massimo Girardis

February 2021

Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...

Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients

Giorgio Berlot
Michele Claudio Vassallo
Nicola Busetto
Margarita Nieto Yabar
Tatiana Istrati
Silvia Baronio
Giada Quarantotto
Mattia Bixio
Giulia Barbati
Roberto Dattola
Irene Longo
Antonino Chillemi
Alice Scamperle
Fulvio Iscra
Ariella Tomasini

December 2018

Abstract Background The administration of endovenous immunoglobulins in patients with septic shock c...

MOESM1 of Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients

Giorgio Berlot (6067076)
Claudio Vassallo (6067079)
Nicola Busetto (6067082)
Margarita Nieto Yabar (6067085)
Tatiana Istrati (6067088)
Silvia Baronio (6067091)
Giada Quarantotto (6067094)
Mattia Bixio (6067097)
Giulia Barbati (4093843)
Roberto Dattola (6067100)
Irene Longo (6067103)
Antonino Chillemi (6067106)
Alice Scamperle (6067109)
Fulvio Iscra (1006)
Ariella Tomasini (6067112)

December 2018

Additional file 1. Adjustment of analyses for severity and periods of enrollment and subgroup analys...

Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol

Stefano Busani
Erika Roat
Martina Tosi
Emanuela Biagioni
Irene Coloretti
Marianna Meschiari
Roberta Gelmini
Lucio Brugioni
Sara De Biasi
Massimo Girardis

January 2021

Septic shock still has a high mortality rate which has not hinted at decreasing in recent years. Un...

IgM and IgA enriched polyclonal immunoglobulins reduce short term mortality in extremely low birth weight infants (ELBW) with sepsis: a retrospective cohort study

Capasso, Letizia
Borrelli, Angela C
Pirozzi, Maria R
Bucci, Laura
Albachiara, Roberta
Ferrara, Teresa
Raimondi, Francesco

January 2018

Immunoglobulin supplementation is a debated strategy in fighting sepsis. We evaluated a polyclonal I...

Efficacy of an IgM preparation in the treatment of patients with sepsis: a double-blind randomized clinical trial in a pediatric intensive care unit

Kola, Ermira
Çelaj, Ermela
Bakalli, Iliriana
Lluka, Robert
Kuli-Lito, Gjeorgjina
Sallabanda, Sashenka

December 2015

Aim: Additional treatments for sepsis to be administered alongside the standard therapy recommended ...

The Role of IgM-Enriched Immunoglobulin (Pentaglobin) in Septic Patients with Hematological Disease

Pedro Amoedo Fernandes
Flávia Tobaldini Russo
Lucas Augusto Monetta da Silva
Lafayete William Ferreira Ramos
Aline de Almeida Simões
Larissa Yukari Okada
Jamilla Neves Cavalcante
Maricy Almeida Viol Ferreira Lopes
Maria Cristina Martins de Almeida Macedo
Roberto Luiz da Silva

April 2021

Background: Patients with hematological disease are 15 times more likely to develop sepsis than the ...

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers

Scarpati G.
Baldassarre D.
Tripepi G.
Boffardi M.
Piazza O.

January 2021

Patients in septic shock with low IgG and IgM serum concentrations have higher mortality rates compa...

Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock

Cavazzuti, Ilaria
Serafini, Giulia
Busani, Stefano
Rinaldi, Laura
Biagioni, Emanuela
Buoncristiano, Marta
Girardis, Massimo

January 2014

To determine whether there was an association between adjunctive therapy with IgM-enriched immunoglo...

Effects of IgM-enriched immunoglobulin therapy in septic-shock-induced multiple organ failure: Pilot study

Toth, Ildiko
Mikor, Andras
Leiner, Tamas
Molnar, Zsolt
Bogar, Lajos
Szakmany, Tamas

August 2013

Mortality due to septic-shock–induced respiratory failure remains high. A recent meta-analysis sugge...

Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum igm-titres versus standard dose in the treatment of septic shock: A randomised controlled trial (igm-fat trial)

Biagioni E.
Tosi M.
Berlot G.
Castiglione G.
Corona A.
De Cristofaro M. G.
Donati A.
Feltracco P.
Forfori F.
Fragranza F.
Murino P.
Piazza O.
Tullo L.
Grasselli G.
D'Amico R.
Girardis M.

January 2021

Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...

Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial)

Patrizia Murino
Emanuela Biagioni
Martina Tosi
Giorgio Berlot
Giacomo Castiglione
Alberto Corona
Maria Giovanna De Cristofaro
Abele Donati
Paolo Feltracco
Francesco Forfori
Fiorentino Fragranza
Ornella Piazza
Livio Tullo
Massimo Girardis

February 2021

Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...

Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients

Giorgio Berlot
Michele Claudio Vassallo
Nicola Busetto
Margarita Nieto Yabar
Tatiana Istrati
Silvia Baronio
Giada Quarantotto
Mattia Bixio
Giulia Barbati
Roberto Dattola
Irene Longo
Antonino Chillemi
Alice Scamperle
Fulvio Iscra
Ariella Tomasini

December 2018

Abstract Background The administration of endovenous immunoglobulins in patients with septic shock c...

MOESM1 of Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients

Giorgio Berlot (6067076)
Claudio Vassallo (6067079)
Nicola Busetto (6067082)
Margarita Nieto Yabar (6067085)
Tatiana Istrati (6067088)
Silvia Baronio (6067091)
Giada Quarantotto (6067094)
Mattia Bixio (6067097)
Giulia Barbati (4093843)
Roberto Dattola (6067100)
Irene Longo (6067103)
Antonino Chillemi (6067106)
Alice Scamperle (6067109)
Fulvio Iscra (1006)
Ariella Tomasini (6067112)

December 2018

Additional file 1. Adjustment of analyses for severity and periods of enrollment and subgroup analys...

Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol

Stefano Busani
Erika Roat
Martina Tosi
Emanuela Biagioni
Irene Coloretti
Marianna Meschiari
Roberta Gelmini
Lucio Brugioni
Sara De Biasi
Massimo Girardis

January 2021

Septic shock still has a high mortality rate which has not hinted at decreasing in recent years. Un...

IgM and IgA enriched polyclonal immunoglobulins reduce short term mortality in extremely low birth weight infants (ELBW) with sepsis: a retrospective cohort study

Capasso, Letizia
Borrelli, Angela C
Pirozzi, Maria R
Bucci, Laura
Albachiara, Roberta
Ferrara, Teresa
Raimondi, Francesco

January 2018

Immunoglobulin supplementation is a debated strategy in fighting sepsis. We evaluated a polyclonal I...

Efficacy of an IgM preparation in the treatment of patients with sepsis: a double-blind randomized clinical trial in a pediatric intensive care unit

Kola, Ermira
Çelaj, Ermela
Bakalli, Iliriana
Lluka, Robert
Kuli-Lito, Gjeorgjina
Sallabanda, Sashenka

December 2015

Aim: Additional treatments for sepsis to be administered alongside the standard therapy recommended ...

The Role of IgM-Enriched Immunoglobulin (Pentaglobin) in Septic Patients with Hematological Disease

Pedro Amoedo Fernandes
Flávia Tobaldini Russo
Lucas Augusto Monetta da Silva
Lafayete William Ferreira Ramos
Aline de Almeida Simões
Larissa Yukari Okada
Jamilla Neves Cavalcante
Maricy Almeida Viol Ferreira Lopes
Maria Cristina Martins de Almeida Macedo
Roberto Luiz da Silva

April 2021

Background: Patients with hematological disease are 15 times more likely to develop sepsis than the ...

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers

Scarpati G.
Baldassarre D.
Tripepi G.
Boffardi M.
Piazza O.

January 2021

Patients in septic shock with low IgG and IgM serum concentrations have higher mortality rates compa...

Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock

Abstract

Extracted data

Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock

Abstract

Extracted data

Related items

Related items